Chemical Compound
2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-D-streptamine; Neomycin A (6CI,7CI,8CI); (+)-Neamine; Dekamycin V; Neamin; Neamine; Nebramycin X; Negamicin; O-2,6-Diamino-2,6-dideoxy-a-D-glucopyranosyl-(1dagger'4)-1,3-diamino-1,2,3-trideoxy-D-myo-inositol; ST 7; Neomycin Imp. A (EP); GW 318764X
CAS Registry Number
3947-65-7
Primary record
2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-D-streptamine; Neomycin A (6CI,7CI,8CI); (+)-Neamine; Dekamycin V; Neamin; Neamine; Nebramycin X; Negamicin; O-2,6-Diamino-2,6-dideoxy-a-D-glucopyranosyl-(1dagger'4)-1,3-diamino-1,2,3-trideoxy-D-myo-inositol; ST 7; Neomycin Imp. A (EP); GW 318764X
- 库存
- 1,495 克
- 纯度
- 99.0 %
- CAS
- 3947-65-7
化合物标识与属性
- CAS
- 3947-65-7
- PubChem CID
- 72392
- SMILES
- C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O)O)N
- Canonical SMILES
- NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O
名称与同义词
- Neamine
- Neomycin A
- Negamicin
- Nebramycin X
- Neamin
- Dekamycin V
- 3947-65-7
- Neamine CRS
- Neamine Disulfate Salt
- Aminoglycoside ST-7
- AC1L2HZM
- NEAMINE [MI]
- RefChem:832126
- Neomycin Sulfate EP Impurity A
- C12H26N4O6
- D0I1NU
- NEOMYCIN A, NEAMINE
- (+)-NEAMINE
- CHEBI:7489
- DTXSID7023358
- UNII-5981U00LY0
- SCHEMBL219578
- MFCD00023857
- SYJXFKPQNSDJLI-HKEUSBCWSA-N
- BDBM8580
- CHEMBL427409
- DTXCID603358
- orb1981778
- ST 7
- 5981U00LY0
- BRN 0026714
- CID72392
- HY-N7449
- ZINC4095654
- BBF-02599
- EX-A10657
- MSK158059
- AKOS025311197
- C12-H26-N4-O6
- DB04808
- J4.461J
- ON32335
- AN-10240
- LS-96092
- 2-Desoxy-4-O-(2,6-diamino-2,6-didesoxy-alpha-D-glucopyranosyl)-D-streptamin
- 4-O-(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-2-deoxy-D-streptamine
- Neomycin Sulfate EP Impurity A (Neamine)
- (2R,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diol
- TOBRAMYCIN IMPURITY C [EP IMPURITY]
- CS-0129171
- NS00011537
- 4-18-00-07474 (Beilstein Handbook Reference)
- C01441
- (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
- 947N657
- A824565
- NEOMYCIN SULFATE IMPURITY A [EP IMPURITY]
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxyoxane-3,4-diol
- D-Streptamine, 2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-
- Q6984256
- N0001-003220
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
- -5-AMINO-2-AMINOMETHYL-6- -TETRAHYDRO-PYRAN-3,4-DIOL
- 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-D-streptamine
- D-Streptamine, 2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl)-
- (1'R,3'S,3S,5R,6R)-5-AMINO-2-AMINOMETHYL-6-(4,6-DIAMINO-2,3-DIHYDROXY-CYCLOHEXYLOXY)-TETRAHYDRO-PYRAN-3,4-DIOL
- (1R,3S,3S,5R,6R)-5-Amino-2-aminomethyl-6-(4,6-diamino-2,3-dihydroxy-cyclohexyloxy)-tetrahydro-pyran-3,4-diol
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}oxane-3,4-diol
- XXX
- 2-Deoxy-4-O-(2,6-diamine-2,6-dideoxy-.alpha.-D-glucopyranosyl)-D-streptamine
- 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-D-streptamine Disulfate Salt
- 5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxy-cyclohexoxy)-tetrahydropyran-3,4-diol
- Framycetin Sulfate EP Impurity A; Neomycin Sulfate EP Impurity A; Tobramycin EP Impurity C
- (1R,2S,3R,5S,6R)-3,5-Diamino-6-[(2,6-dideoxy-2,6-diamino-alpha-D-glucopyranosyl)oxy]cyclohexane-1,2-diol
- (1S)-3alpha-[(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)oxy]-4beta,6beta-diaminocyclohexane-1alpha,2beta-diol
- (1S,2R,3R,4S,6R)-3-[(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)oxy]-4,6-diaminocyclohexane-1,2-diol
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol
- (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyloxy)-tetrahydro-2H-pyran-3,4-diol
- (2R,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-[[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy]tetrahydro-2H-pyran-3,4-diol
- (2R,3S,4R,5R,6R)-5-Amino-2-aminomethyl-6-[[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexane-1-yl]oxy]-tetrahydro-2H-pyran-3,4-diol
- (2R,3S,4R,5R,6R)-6-((1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3-DIHYDROXYCYCLOHEXYLOXY)-5-AMINO-2-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-3,4-DIOL
- 1-O-[(1alpha)-2beta,4beta-Diamino-5alpha,6beta-dihydroxycyclohexyl]-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranose
- 1-O-[(1R)-2alpha,3beta-Dihydroxy-4alpha,6alpha-diaminocyclohexan-1beta-yl]-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranose
- 1-O-[(1R,2R,3S,4R,6S)-2,3-Dihydroxy-4,6-diaminocyclohexan-1-yl]-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranose
- 1-O-[(1R,2S,4R,5S,6R)-2,4-Diamino-5,6-dihydroxycyclohexyl]-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranose
- 1404-04-2
- 1406-04-8
- 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-D-streptamine Disulfate Salt; Neomycin A Disulfate Salt
- 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-D-streptamine; Neomycin A (6CI,7CI,8CI); (+)-Neamine; Dekamycin V; Neamin; Neamine; Nebramycin X; Negamicin; O-2,6-Diamino-2,6-dideoxy-a-D-glucopyranosyl-(1dagger'4)-1,3-diamino-1,2,3-trideoxy-D-myo-inositol; ST 7; Neomycin Imp. A (EP); GW 318764X
- 3alpha,5alpha-Diamino-6beta-[(2,6-dideoxy-2,6-diamino-alpha-D-glucopyranosyl)oxy]cyclohexane-1alpha,2beta-diol
- 998-897-5
- O-2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-1,3-DIAMINO-1,2,3-TRIDEOXY-D-MYO-INOSITOL
- O-2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL-(1->4)-1,3-DIAMINO-1,2,3-TRIDEOXY-D-MYO-INOSITOL